Selective Targeting of a Novel Vasodilator to the Uterine Vasculature to Treat Impaired Uteroplacental Perfusion in Pregnancy. (2017)

First Author: Cureton N
Attributed to:  Use of nanoparticles to deliver growth signals to the placenta funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7150/thno.19678

PubMed Identifier: 29109771

Publication URI: http://europepmc.org/abstract/MED/29109771

Type: Journal Article/Review

Volume: 7

Parent Publication: Theranostics

Issue: 15

ISSN: 1838-7640